In mammals, five tissue-specific PAD isozymes have been identified [21], with PADs and post-translational deimination widely studied in the past few years in relation to various pathologies including autoimmune diseases, central nervous system (CNS) pathologies and cancer [14,19,21,22,23,24]. The gene discussed is PADI4; the disease is cancer.